152 related articles for article (PubMed ID: 37975869)
1. Immunotherapy, a new approach for the treatment of human pain.
Goode DJ
Pain; 2024 Apr; 165(4):725-726. PubMed ID: 37975869
[No Abstract] [Full Text] [Related]
2. Dexmedetomidine and hydromorphone: a novel pain management strategy for the oncology ward setting during anti-GD2 immunotherapy for high-risk neuroblastoma in children.
Görges M; West N; Deyell R; Winton P; Cheung W; Lauder G
Pediatr Blood Cancer; 2015 Jan; 62(1):29-34. PubMed ID: 25263424
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy associated pain crisis and the haemophagocytic lymphohistiocytosis syndrome in advanced melanoma: Case report and review of the literature.
Krasovitsky M; Borbasi J
Palliat Med; 2021 May; 35(5):972-976. PubMed ID: 33761792
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapies in chronic pain through modulation of neuroimmune interactions.
Zhao J; Huh Y; Bortsov A; Diatchenko L; Ji RR
Pharmacol Ther; 2023 Aug; 248():108476. PubMed ID: 37307899
[TBL] [Abstract][Full Text] [Related]
5. Calcium Carbonate/Polydopamine Composite Nanoplatform Based on TGF-β Blockade for Comfortable Cancer Immunotherapy.
Li Y; Wang D; Sun J; Hao Z; Tang L; Sun W; Zhang X; Wang P; Ruiz-Alonso S; Pedraz JL; Kim HW; Ramalingam M; Xie S; Wang R
ACS Appl Mater Interfaces; 2024 Jan; 16(3):3187-3201. PubMed ID: 38206677
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma Showing Tumor Shrinkage Due to an Abscopal Effect.
Yano R; Hirooka M; Morita M; Okazaki Y; Nakamura Y; Imai Y; Watanabe T; Koizumi Y; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
Intern Med; 2024 Jan; 63(2):241-246. PubMed ID: 37197962
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study.
Zhuang XY; Li M; Xu DM; Lin SB; Yang ZL; Xu TY; Yin J
Health Sci Rep; 2024 Feb; 7(2):e1884. PubMed ID: 38352696
[TBL] [Abstract][Full Text] [Related]
8. "No pain, No gain" still true with immunotherapy: When the finger shows the moon, look at the moon!
Milano G; Innocenti F; Lacarelle B; Ciccolini J
Crit Rev Oncol Hematol; 2018 Jul; 127():1-5. PubMed ID: 29891106
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy improved cancer related pain management in patients with advanced Hepato-Pancreatic Biliary Cancers: A propensity score-matched (PSM) analysis.
Wu X; Qin F; Zhang Q; Qiao J; Qi Y; Liu B
Front Oncol; 2022; 12():914591. PubMed ID: 36212482
[TBL] [Abstract][Full Text] [Related]
10. [A woman in her eighties with chest pain during immunotherapy for melanoma].
Karlsen TLS; Karlsen J; Mo R; Hammer T
Tidsskr Nor Laegeforen; 2021 Sep; 141(2021-12):. PubMed ID: 34505493
[TBL] [Abstract][Full Text] [Related]
11. Intralesional immunotherapy compared to cryotherapy in the treatment of warts.
Khozeimeh F; Jabbari Azad F; Mahboubi Oskouei Y; Jafari M; Tehranian S; Alizadehsani R; Layegh P
Int J Dermatol; 2017 Apr; 56(4):474-478. PubMed ID: 28108992
[TBL] [Abstract][Full Text] [Related]
12. Allergen-specific subcutaneous immunotherapy-pain evaluation in pediatric age.
Ferreira C; Rezende I; Guilherme A; Lopes I
Allergol Immunopathol (Madr); 2021; 49(1):58-61. PubMed ID: 33528930
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy-Responsive Neuropathic Pain and Allodynia in a Patient With Glycine Receptor Autoantibodies: A Case Report.
Soleimani B; Board C; Yu T; Tracey I; Irani SR; Foley P
Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37640544
[TBL] [Abstract][Full Text] [Related]
14. The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
D'Haese JG; Demir IE; Kehl T; Winckler J; Giese NA; Bergmann F; Giese T; Büchler MW; Friess H; Hartel M; Ceyhan GO
BMC Gastroenterol; 2013 Jan; 13():14. PubMed ID: 23324439
[TBL] [Abstract][Full Text] [Related]
15. Unpleasant symptoms of immunotherapy for people with lung cancer: A mixed-method study.
Zhang J; Wang S; Zhou Z; Lei C; Yu H; Zeng C; Xia X; Qiao G; Shi Q
Int J Nurs Stud; 2023 Mar; 139():104430. PubMed ID: 36638590
[TBL] [Abstract][Full Text] [Related]
16. Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.
Daveson AJM; Ee HC; Andrews JM; King T; Goldstein KE; Dzuris JL; MacDougall JA; Williams LJ; Treohan A; Cooreman MP; Anderson RP
EBioMedicine; 2017 Dec; 26():78-90. PubMed ID: 29191561
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for the management of cancer pain.
Amaya F
Ann Palliat Med; 2020 Jul; 9(4):1358-1360. PubMed ID: 32527138
[No Abstract] [Full Text] [Related]
18. Effect of baseline cancer pain on the efficacy of immunotherapy in lung cancer patients.
Zhou H; Wei J; Sun W; Song Z
J Thorac Dis; 2023 Aug; 15(8):4314-4323. PubMed ID: 37691656
[TBL] [Abstract][Full Text] [Related]
19. Targeting the chemokine ligand 2-chemokine receptor 2 axis provides the possibility of immunotherapy in chronic pain.
Liu S; Lan XB; Tian MM; Zhu CH; Ma L; Yang JM; Du J; Zheng P; Yu JQ; Liu N
Eur J Pharmacol; 2023 May; 947():175646. PubMed ID: 36907261
[TBL] [Abstract][Full Text] [Related]
20. Immunology and Immunotherapy of Endometriosis.
Maksym RB; Hoffmann-Młodzianowska M; Skibińska M; Rabijewski M; Mackiewicz A; Kieda C
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
